Atrial Fibrillation

Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Savaysa (edoxaban) tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with...

July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t respond to medication, suggests preliminary research presented at the 56th annual me...

Medtronic Inc. announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) clinical trial, published in The New England Journal of Medicine. The trial found that continuous cardiac monitoring with the Reveal XT in...

April 10, 2014 — The 2014 Guideline for the Management of Patients With Atrial Fibrillation includes recommendations for an increased use of radio frequency (RF) ablation in the treatment of non-valvular atrial fibrillation, the addition of three...

Savaysa, Daiichi Sankyo, edoxaban, FDA, approval, NVAF, thromboembolism
Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Savaysa (edoxaban) tablets, an oral, once-daily selective...
CardioFocus, HeartLight Endoscopic Ablation System, Japan Lifeline, distribution
CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation (AF), announced that it has executed an...
Ablation Systems, Atrial Fibrillation, EP Lab, Clinical Trial/Study
Medtronic, Inc. announced the initiation of a randomized clinical trial in Europe to assess the benefits of ablation using the Medtronic Artic Front Advance...
AliveCor Heart Monitor, third generation, ECG, atrial fibrillation, AF
AliveCor Inc. announced the launch of its third-generation AliveCor Heart Monitor. Now users have the ability to identify and manage heart conditions with...
Savaysa, Daiichi Sankyo, edoxaban, FDA, approval, NVAF, thromboembolism
Savaysa (edoxaban) tablets from Daiichi Sankyo Co. Ltd. are an oral, once-daily selective factor Xa-inhibitor to reduce the risk of stroke
Zontivity (vorapaxar) tablets reduce the risk of heart attack, stroke, cardiovascular death and need for procedures to restore the blood...
Atherotech Diagnostics Lab offers warfarin sensitivity, Plavix sensitivity and thrombophilia risk tests. The warfarin and Plavix...
The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K...

Articles

AHA, warfarin, antiplatelet therapy, atrial fibrillation, anti-clotting, EP lab
Long-term overtreatment with the anti-clotting drug warfarin combined with antiplatelet therapy to prevent stroke may raise the risk of dementia in people with...
Topera, Abbott, FIRMap, rotors, rotor mapping
Abbott has entered into an agreement to purchase Topera Inc., a private, venture-backed medical device company focused on developing electrophysiology...
alivecore, alivercor, smartphone ECG, AF, Afrib, atrial fibrillation
September 29, 2014 — AliveCor announced the launch of the latest version of the AliveECG app, which provides patients with free real-time atrial fibrillation (...
September 26, 2014 — The American Association for Thoracic Surgery (AATS) has released new evidence-based guidelines for the prevention and treatment of...

Video Center

The America College of Cardiology has released its list of key late-breaking clinical trials at the...
4 days 18 hours ago
As editor of DAIC, I keep a close watch on trends in cardiovascular technology and try to predict...
3 weeks 4 days ago
There were a few intriguing technology trends at the Radiological Society of North America (RSNA)...
5 weeks 2 days ago
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...

Comparison Charts

Sorry there is no data available